Home
About Us
Events
Contact Us
Morning refreshments and networking
Post navigation
Previous:
Case Study: First-in-Class Mitochondrial Uncoupler MP101 in Sporadic Amyotrophic Lateral Sclerosis
Next:
Partnering with Non-Profits in Rare Disease Drug Development: Collaboration, Licensing, and Emerging Models
